The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2011

Filed:

Jul. 23, 2007
Applicants:

Angela Berry, Gaylordsville, CT (US);

Pier Francesco Cirillo, Woodbury, CT (US);

Eugene Richard Hickey, Danbury, CT (US);

Doris Riether, Newtown, CT (US);

David S. Thomson, Ridgefield, CT (US);

Monika Ermann, Wantage, GB;

James Edward Jenkins, Hungerford, GB;

Innocent Mushi, Didcot, GB;

Malcolm Taylor, Didcot, GB;

Christopher Francis Palmer, Abingdon, GB;

Nigel Blumire, Didcot, GB;

Inventors:

Angela Berry, Gaylordsville, CT (US);

Pier Francesco Cirillo, Woodbury, CT (US);

Eugene Richard Hickey, Danbury, CT (US);

Doris Riether, Newtown, CT (US);

David S. Thomson, Ridgefield, CT (US);

Monika Ermann, Wantage, GB;

James Edward Jenkins, Hungerford, GB;

Innocent Mushi, Didcot, GB;

Malcolm Taylor, Didcot, GB;

Christopher Francis Palmer, Abingdon, GB;

Nigel Blumire, Didcot, GB;

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 213/75 (2006.01); C07D 403/12 (2006.01); A61K 31/44 (2006.01); A61P 29/00 (2006.01); A61P 37/00 (2006.01); C07C 317/44 (2006.01); C07C 215/38 (2006.01); C07D 217/22 (2006.01); C07D 231/40 (2006.01); C07D 261/12 (2006.01); C07D 277/46 (2006.01); C07D 277/82 (2006.01); C07D 309/04 (2006.01); C07D 405/12 (2006.01); C07D 407/12 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compound of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.


Find Patent Forward Citations

Loading…